Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine in ALS
NCT00005674Phase 2Completed
- Sponsor
- National Center for Research Resources
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of creatine in amyotrophic lateral sclerosis (ALS), sponsored by National Center for Research Resources. Status: completed.
02
Drugs
creatine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00005674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005674.